News
3hon MSNOpinion
OpEd: Many of Markey’s clinical trials funded by the NIH give Kentucky patients access to the latest treatments — including ...
A research team led by Prof. Li Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has ...
Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...
Mike Dovidio says adding scanning power can make drug spending more efficient — and save some patients' lives.
22h
Sportschosun on MSNYonsei Cancer Hospital expands baryon treatment in the second half of the year...Advanced Integrated...Yonsei Cancer Hospital will launch its vision of an integrated cancer treatment platform in the second half of this year with ...
Boehringer Ingelheim shares how it is addressing healthcare inequalities in cancer care, with a particular emphasis on ...
The results suggest toxicity may not be as pervasive as previously thought, which argues for more-personalized monitoring.
10h
Stockhead on MSNHealth Check: Mayne Pharma shareholders back $600m ‘phantom’ takeover offerMayne Pharma (ASX:MYX) shareholders have overwhelmingly approved the company’s $600 million takeover scheme of arrangement, ...
The partners have committed to awarding two grants, totaling around $2.3 million, to researchers studying this lung cancer subset.
Research and development expenses for the fiscal year ended March 31, 2025 were $16.9 million compared with $24.4 million for the fiscal year ended March 31, 2024. The decrease of $7.5 million was ...
Like a lot of people, I’d had some squamous cell carcinomas removed from my scalp. But in June, 2024, a red splotch, about the size of my fist, appeared on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results